This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2026.
Company Filing History:
1 out of 3,298 
1 out of 5,024 
Years Active: 2026
Title: Aurelien Viaccoz: Innovator in Multiple Sclerosis Treatment
Introduction
Aurelien Viaccoz is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of relapsing multiple sclerosis. His innovative approach has garnered attention in the scientific community.
Latest Patents
Aurelien Viaccoz holds a patent for "Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase." This patent outlines methods for treating Relapsing Multiple Sclerosis (RMS) by administering approximately 200 mg of fenebrutinib twice daily, or an equivalent amount of a pharmaceutically acceptable salt thereof. This advancement represents a promising avenue for patients suffering from this debilitating condition.
Career Highlights
Throughout his career, Aurelien has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug development and treatment methodologies.
Collaborations
Aurelien has collaborated with esteemed colleagues such as Edmond Huatung Teng and Hideki Garren. These partnerships have contributed to the advancement of research and development in the field of multiple sclerosis treatment.
Conclusion
Aurelien Viaccoz is a distinguished inventor whose work in treating relapsing multiple sclerosis has the potential to improve the lives of many patients. His innovative methods and collaborations highlight his commitment to advancing medical science.